+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Glucose Monitoring Systems Market - Global Forecast 2026-2032- Product Image
Continuous Glucose Monitoring Systems Market - Global Forecast 2026-2032- Product Image
Sale

Continuous Glucose Monitoring Systems Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337735
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Continuous Glucose Monitoring Systems Market is projected to reach USD 5.14 Billion in 2026. It is expected to continue growing at a CAGR of 7.50%, reaching USD 7.95 Billion by 2032.

Continuous glucose monitoring (CGM) systems have moved from a specialist diabetes technology to a core digital health platform for insulin-treated diabetes, high-risk type 2 diabetes management, remote patient monitoring, pregnancy diabetes care, and emerging metabolic health programs. Unlike episodic fingerstick testing, CGM devices generate continuous interstitial glucose data, helping patients and clinicians understand time in range, hypoglycemia risk, glycemic variability, and treatment response.

The market is supported by a large and persistent clinical need. The International Diabetes Federation reports that hundreds of millions of adults live with diabetes globally, while the U.S. Centers for Disease Control and Prevention estimates that more than 38 million Americans have diabetes. This burden, combined with clinical evidence linking improved glucose visibility to better diabetes self-management, is accelerating adoption of real-time CGM, intermittently scanned CGM, integrated insulin delivery, and cloud-connected analytics.

Transformative Shifts in the CGM Landscape

The CGM landscape is being reshaped by three structural shifts: broader reimbursement, stronger evidence for clinical utility, and rapid consumerization of diabetes technology. Payers in the United States and several European markets have expanded coverage beyond type 1 diabetes into selected insulin-treated type 2 diabetes populations, improving access and normalizing CGM as a standard care tool rather than a premium add-on.

Technology is also shifting from standalone sensors toward connected care ecosystems. Smaller sensors, longer wear duration, factory calibration, smartphone connectivity, remote data sharing, and integration with automated insulin delivery systems are raising patient expectations. At the same time, healthcare systems are using CGM-derived metrics such as time in range, time above range, and time below range to complement HbA1c, enabling more actionable clinical decision-making.

Cumulative Impact of Artificial Intelligence in CGM

Artificial intelligence is compounding CGM value by turning high-frequency glucose signals into predictive, personalized, and clinically usable insights. AI-enabled algorithms can identify glucose trends, estimate hypoglycemia risk, support insulin dosing decisions under regulated conditions, and reduce alert fatigue by prioritizing the most clinically relevant notifications.

The cumulative impact is strongest when AI is embedded across connected devices, electronic health records, telehealth workflows, and population health platforms. However, industry leaders must manage model validation, cybersecurity, data privacy, explainability, and regulatory expectations. In CGM, AI adoption will be judged less by novelty and more by measurable improvements in time in range, severe hypoglycemia reduction, clinician workflow efficiency, and patient adherence.

Key Regional Insights

North America remains one of the most mature CGM regions, led by the United States, where specialist adoption, expanded Medicare coverage for eligible insulin users, strong device innovation, and integration with automated insulin delivery support market depth. Canada benefits from provincial reimbursement progress and diabetes technology advocacy, although coverage variation continues to shape access.

Europe is characterized by structured reimbursement, strong clinical guideline influence, and broad adoption in countries such as Germany, France, the United Kingdom, Italy, and Spain. The European emphasis on health technology assessment places pressure on manufacturers to demonstrate real-world outcomes, budget impact, device safety, and patient-reported benefits under evolving medical device and health data requirements.

Asia-Pacific is the highest-potential adoption region because it combines large diabetes populations with rising healthcare digitization. China, India, Japan, South Korea, and Australia each present distinct adoption pathways, from hospital-led diabetes care and local manufacturing to reimbursement-backed technology use. Latin America is advancing through private care, urban specialist networks, and gradual public-sector interest, with Brazil and Mexico serving as important demand centers. The Middle East, especially GCC countries, benefits from high diabetes prevalence and investment in digital health infrastructure, while Africa remains earlier in adoption due to affordability, distribution, and reimbursement constraints despite a rising diabetes burden.

Key Group Insights

The European Union is a critical CGM policy and reimbursement bloc because medical device regulation, health technology assessment, data protection, and cross-border clinical evidence requirements influence commercial strategy. The G7 markets collectively represent high-value demand, sophisticated reimbursement systems, advanced diabetes care infrastructure, and strong post-market evidence expectations, making them central to premium CGM launches and clinical validation.

BRICS economies are becoming increasingly important as diabetes prevalence, urbanization, local manufacturing capability, and digital health investment expand. China and India are especially influential because of population scale and growing demand for affordable continuous monitoring. ASEAN markets show uneven but promising adoption, with private hospitals, employer health programs, and digital care models driving early uptake in urban centers. GCC countries are attractive due to high diabetes risk, public health investment, and national digital health strategies. NATO membership itself is not a healthcare market variable, but many NATO countries overlap with high-income North American and European systems where reimbursement, cybersecurity, procurement continuity, and supply-chain resilience are strategic priorities.

Key Country Insights

The United States leads global CGM commercialization through broad clinical adoption, strong reimbursement momentum, advanced endocrinology networks, and rapid integration with insulin pumps and digital therapeutics. Canada is expanding access through provincial programs, while Mexico and Brazil are building demand through private healthcare, specialist-led care, and rising awareness of diabetes complications.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are key countries where national health systems, clinical guidelines, and evidence-based reimbursement shape adoption. Germany and France emphasize structured reimbursement and outcomes evidence, while the United Kingdom benefits from national diabetes care pathways and procurement frameworks. Russia presents a more complex environment influenced by procurement processes, import dynamics, currency pressure, and healthcare system constraints.

China and India anchor Asia-Pacific volume potential due to large diabetes populations, digital health adoption, and growing domestic medtech capabilities. Japan, South Korea, and Australia represent higher-access markets with advanced clinical practice, technology acceptance, and stronger reimbursement or insurance pathways. Across these countries, the strongest CGM opportunities are tied to affordability, local clinical evidence, clinician training, patient education, and integration into routine diabetes management.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation that links CGM use to time in range improvement, hypoglycemia reduction, fewer acute events, improved pregnancy diabetes management, and better clinician workflow. Real-world evidence is especially important for payer expansion into insulin-treated type 2 diabetes and broader cardiometabolic risk programs.

Manufacturers should design region-specific access strategies, including premium integrated systems for mature markets and lower-cost, high-reliability devices for price-sensitive markets. Partnerships with endocrinologists, primary care networks, pharmacies, telehealth providers, and payers can reduce onboarding friction. Leaders should also invest in interoperable platforms, AI governance, cybersecurity, regulatory readiness, and patient education to improve retention and clinical trust.

Research Methodology

This executive summary is based on a structured review of verified public sources, including diabetes epidemiology from international health organizations, public health agencies, national reimbursement policies, clinical guideline updates, regulatory developments, device approval information, and peer-reviewed evidence on CGM outcomes.

The research approach triangulates demand-side indicators, including diabetes prevalence, insulin use, reimbursement coverage, clinical guideline support, and digital health readiness, with supply-side factors such as sensor innovation, manufacturing scale, regulatory approvals, distribution models, and interoperability. Regional and country insights are synthesized to identify adoption maturity, market barriers, and growth catalysts without relying on unverified projections.

Conclusion

Continuous glucose monitoring systems are becoming a foundational technology in modern diabetes care. The market is advancing because CGM delivers clinically meaningful data, supports personalized therapy, enables remote care, and aligns with healthcare system goals to prevent costly diabetes complications.

The next phase of growth will depend on affordability, payer confidence, interoperable data ecosystems, AI-enabled decision support, regulatory clarity, and evidence demonstrating benefits across broader patient populations. Organizations that combine validated technology, strong clinical partnerships, and market-specific access strategies will be best positioned to lead the global CGM systems market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Continuous Glucose Monitoring Systems Market, by Component
7.1. Introduction
7.2. Receivers/Monitors
7.3. Sensors
7.4. Transmitters
8. Continuous Glucose Monitoring Systems Market, by Type of Device
8.1. Introduction
8.2. Integrated CGM Systems
8.3. Standalone CGM Systems
9. Continuous Glucose Monitoring Systems Market, by Duration of Use
9.1. Introduction
9.2. Long-Term Implantable CGMs
9.3. Short-Term Wearable CGMs
10. Continuous Glucose Monitoring Systems Market, by Patient Age Group
10.1. Introduction
10.2. Adults
10.3. Children
10.4. Geriatric
11. Continuous Glucose Monitoring Systems Market, by Application
11.1. Introduction
11.2. Gestational Diabetes
11.3. Type 1 Diabetes
11.4. Type 2 Diabetes
12. Continuous Glucose Monitoring Systems Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
12.3.1. eCommerce Platforms
12.3.2. Manufacturer Websites
13. Continuous Glucose Monitoring Systems Market, by End User
13.1. Introduction
13.2. Ambulatory Surgical Centers
13.3. Home Care Settings
13.4. Hospitals & Clinics
13.4.1. Inpatient Pharmacies
13.4.2. Outpatient Pharmacies
14. Continuous Glucose Monitoring Systems Market, by Region
14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa
15. Continuous Glucose Monitoring Systems Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Continuous Glucose Monitoring Systems Market, by Country
16.1. United States
16.2. Germany
16.3. China
16.4. United Kingdom
16.5. India
16.6. Japan
16.7. Russia
16.8. Brazil
16.9. Canada
16.10. Italy
16.11. Mexico
16.12. France
16.13. Spain
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. A. Menarini IFR S.r.l.
18.2. Abbott Laboratories
18.3. AgaMatrix Inc. by I-Sens Inc.
18.4. Ascensia Diabetes Care Holdings AG
18.5. Biorasis, Inc.
18.6. Dexcom, Inc.
18.7. F. Hoffmann-La Roche Ltd.
18.8. GlucoRx Limited
18.9. Glysens Incorporated
18.10. i-SENS, Inc.
18.11. Insulet Corporation
18.12. Johnson & Johnson Services, Inc.
18.13. Medtronic PLC
18.14. Medtrum Technologies Inc.
18.15. Nemaura Medical Inc.
18.16. Novo Nordisk A/S
18.17. NXP Semiconductors N.V.
18.18. OSANG Healthcare Co., Ltd.
18.19. Sanwa Kagaku Kenkyusho Co., Ltd.
18.20. Senseonics Holdings Inc.
18.21. Sibionics
18.22. Signos, Inc.
18.23. STMicroelectronics N.V.
18.24. TaiDoc Technology Corporation
18.25. Tandem Diabetes Care, Inc.
18.26. Texas Instruments Incorporated
18.27. WaveForm Technologies, Inc.
18.28. Ypsomed Holding AG
18.29. Zhejiang POCTech Co., Ltd.
List of Figures
FIGURE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL RECEIVERS/MONITORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL RECEIVERS/MONITORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL RECEIVERS/MONITORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SENSORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL TRANSMITTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL TRANSMITTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL TRANSMITTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL INTEGRATED CGM SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL INTEGRATED CGM SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INTEGRATED CGM SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL STANDALONE CGM SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL STANDALONE CGM SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL STANDALONE CGM SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL LONG-TERM IMPLANTABLE CGMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LONG-TERM IMPLANTABLE CGMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL LONG-TERM IMPLANTABLE CGMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SHORT-TERM WEARABLE CGMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SHORT-TERM WEARABLE CGMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SHORT-TERM WEARABLE CGMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ADULTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ADULTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ADULTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CHILDREN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CHILDREN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CHILDREN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL INPATIENT PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL INPATIENT PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL INPATIENT PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL OUTPATIENT PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL OUTPATIENT PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL OUTPATIENT PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 107. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 109. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 110. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 111. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 112. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 113. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 114. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 115. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 127. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 129. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 130. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 131. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 132. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 133. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 134. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 135. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 136. AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 140. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 141. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 142. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 143. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 144. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 145. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 146. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. ASEAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 148. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 150. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 151. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 152. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 153. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 154. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 155. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 156. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. GCC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 168. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 170. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 171. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 172. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 173. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 174. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 175. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 176. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 177. BRICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 178. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 179. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 180. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 181. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 182. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 183. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 184. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 185. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 186. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. G7 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 188. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 189. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 190. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 191. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 192. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 193. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 194. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 195. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 196. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. NATO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 198. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 199. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 200. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 201. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 202. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 203. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 204. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 205. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 209. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 210. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 211. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 212. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 213. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 214. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 215. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 216. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 217. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 219. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 220. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 221. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 222. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 223. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 224. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 225. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 226. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 227. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 228. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 233. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 234. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 236. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 239. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 241. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 242. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 243. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 244. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 245. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 246. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 247. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 249. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 250. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 251. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 252. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 253. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 254. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 255. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 256. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 257. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 259. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 261. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 262. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 263. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 264. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 265. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 266. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 267. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 268. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 269. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 270. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 271. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 272. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 273. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 274. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 275. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 276. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 277. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 279. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 281. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 282. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 283. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 284. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 285. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 286. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 287. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 289. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 290. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 291. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 292. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 293. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 294. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 295. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 296. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 297. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 299. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 301. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 302. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 303. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 304. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 305. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 306. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 307. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 309. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 310. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 311. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2017-2032 (USD MILLION)
TABLE 312. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2017-2032 (USD MILLION)
TABLE 313. FRANCE CONTINUOUS GLUCOSE MON

Companies Mentioned

  • A. Menarini IFR S.r.l.
  • Abbott Laboratories
  • AgaMatrix Inc. by I-Sens Inc.
  • Ascensia Diabetes Care Holdings AG
  • Biorasis, Inc.
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlucoRx Limited
  • Glysens Incorporated
  • i-SENS, Inc.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Nemaura Medical Inc.
  • Novo Nordisk A/S
  • NXP Semiconductors N.V.
  • OSANG Healthcare Co., Ltd.
  • Sanwa Kagaku Kenkyusho Co., Ltd.
  • Senseonics Holdings Inc.
  • Sibionics
  • Signos, Inc.
  • STMicroelectronics N.V.
  • TaiDoc Technology Corporation
  • Tandem Diabetes Care, Inc.
  • Texas Instruments Incorporated
  • WaveForm Technologies, Inc.
  • Ypsomed Holding AG
  • Zhejiang POCTech Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.14 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.95 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Continuous Blood Glucose Monitoring Systems Market - Global Forecast 2026-2032 - Product Image

Continuous Blood Glucose Monitoring Systems Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Glucose Monitoring Devices Market - Global Forecast 2026-2032 - Product Image

Glucose Monitoring Devices Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Blood Glucose Monitoring Systems - Global Strategic Business Report - Product Image

Blood Glucose Monitoring Systems - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Global Forecast to 2030 - Product Image

Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Global Forecast to 2030

  • Report
  • 302 Pages
  • Global
From
Continuous Glucose Monitoring Systems Market Size, Share, Trends and Forecast by Component, Demographics, End User, and Region, 2026-2034 - Product Image

Continuous Glucose Monitoring Systems Market Size, Share, Trends and Forecast by Component, Demographics, End User, and Region, 2026-2034

  • Report
  • 150 Pages
  • Global
From

About the Continuous Glucose Monitoring Market

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low. Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.